Compared to the control group, the asparaginase, anti-PD-L1, and combination therapy groups all significantly inhibited tumor growth, with the most pronounced therapeutic effect observed in the combination therapy group (Figure 4D). This evidence concerns the gene CD274 and neoplasm.